^Diment S, Martin KJ, Stahl PD. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. The Journal of Biological Chemistry. August 1989, 264 (23): 13403–6. PMID 2760027. doi:10.1016/S0021-9258(18)80010-2.
^Minarowska A, Gacko M, Karwowska A, Minarowski Ł. Human cathepsin D. Folia Histochemica et Cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society. 2008, 46 (1): 23–38. PMID 18296260. doi:10.2478/v10042-008-0003-x.
^Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Research. July 1988, 48 (13): 3688–92. PMID 3378211.
^Authier F, Metioui M, Fabrega S, Kouach M, Briand G. Endosomal proteolysis of internalized insulin at the C-terminal region of the B chain by cathepsin D. The Journal of Biological Chemistry. March 2002, 277 (11): 9437–46. PMID 11779865. doi:10.1074/jbc.M110188200.
^Baechle D, Flad T, Cansier A, Steffen H, Schittek B, Tolson J, et al. Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. The Journal of Biological Chemistry. March 2006, 281 (9): 5406–15. PMID 16354654. doi:10.1074/jbc.M504670200.
^Bańkowska A, Gacko M, Chyczewska E, Worowska A. Biological and diagnostic role of cathepsin D. Roczniki Akademii Medycznej W Białymstoku. 1997,. 42 Suppl 1: 79–85. PMID 9337526.
^Lkhider M, Castino R, Bouguyon E, Isidoro C, Ollivier-Bousquet M. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions. Journal of Cell Science. October 2004, 117 (Pt 21): 5155–64. PMID 15456852. doi:10.1242/jcs.01396.
^Traynor JP, Oun HA, McKenzie P, Shilliday IR, McKay IG, Dunlop A, Geddes CC, Mactier RA. Assessing the utility of the stop dialysate flow method in patients receiving haemodiafiltration. Nephrology, Dialysis, Transplantation. November 2005, 20 (11): 2479–84. PMID 16046508. doi:10.1093/ndt/gfi021.
^Menzer G, Müller-Thomsen T, Meins W, Alberici A, Binetti G, Hock C, Nitsch RM, Stoppe G, Reiss J, Finckh U. Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. American Journal of Medical Genetics. March 2001, 105 (2): 179–82. PMID 11304834. doi:10.1002/ajmg.1204.
^Haidar B, Kiss RS, Sarov-Blat L, Brunet R, Harder C, McPherson R, Marcel YL. Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux. The Journal of Biological Chemistry. December 2006, 281 (52): 39971–81. PMID 17032648. doi:10.1074/jbc.M605095200.
^Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. The Journal of Antibiotics. May 1970, 23 (5): 259–62. PMID 4912600. doi:10.7164/antibiotics.23.259.
^Kim SJ, Kim KH, Ahn ER, Yoo BC, Kim SY. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival. Amino Acids. January 2013, 44 (1): 73–80. PMID 21960143. S2CID 17149825. doi:10.1007/s00726-011-1089-6.
^Devosse T, Dutoit R, Migeotte I, De Nadai P, Imbault V, Communi D, Salmon I, Parmentier M. Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3. Journal of Immunology. August 2011, 187 (3): 1475–85. PMID 21709160. doi:10.4049/jimmunol.1003545.
^Mariani E, Seripa D, Ingegni T, Nocentini G, Mangialasche F, Ercolani S, Cherubini A, Metastasio A, Pilotto A, Senin U, Mecocci P. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. Journal of the Neurological Sciences. September 2006, 247 (2): 187–91. PMID 16784755. S2CID 34224448. doi:10.1016/j.jns.2006.05.043.
Conner GE, Richo G. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. Biochemistry. February 1992, 31 (4): 1142–7. PMID 1734961. doi:10.1021/bi00119a024.
Fujita H, Tanaka Y, Noguchi Y, Kono A, Himeno M, Kato K. Isolation and sequencing of a cDNA clone encoding rat liver lysosomal cathepsin D and the structure of three forms of mature enzymes. Biochemical and Biophysical Research Communications. August 1991, 179 (1): 190–6. PMID 1883350. doi:10.1016/0006-291X(91)91353-E.
Dunn AD, Crutchfield HE, Dunn JT. Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L. The Journal of Biological Chemistry. October 1991, 266 (30): 20198–204. PMID 1939080. doi:10.1016/S0021-9258(18)54909-7.
Redecker B, Heckendorf B, Grosch HW, Mersmann G, Hasilik A. Molecular organization of the human cathepsin D gene. DNA and Cell Biology. 1991, 10 (6): 423–31. PMID 2069717. doi:10.1089/dna.1991.10.423.
Conner GE, Udey JA. Expression and refolding of recombinant human fibroblast procathepsin D. DNA and Cell Biology. 1990, 9 (1): 1–9. PMID 2180427. doi:10.1089/dna.1990.9.1.
Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Research. July 1989, 49 (14): 3904–9. PMID 2736531.
Lenarcic B, Kos J, Dolenc I, Lucovnik P, Krizaj I, Turk V. Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochemical and Biophysical Research Communications. July 1988, 154 (2): 765–72. PMID 3261170. doi:10.1016/0006-291X(88)90206-9.
Terayama H, Fukuzumi R. Ubiquitous presence of calciferin-like and cathepsin D-like activities in the sera (vertebrates) and humoral fluids (invertebrates). Comparative Biochemistry and Physiology. B, Comparative Biochemistry. 1987, 87 (4): 675–9. PMID 3665421. doi:10.1016/0305-0491(87)90373-7.
Sekiguchi K, Siri A, Zardi L, Hakomori S. Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies. The Journal of Biological Chemistry. April 1985, 260 (8): 5105–14. PMID 3988746. doi:10.1016/S0021-9258(18)89185-2.
Lemansky P, Gieselmann V, Hasilik A, von Figura K. Cathepsin D and beta-hexosaminidase synthesized in the presence of 1-deoxynojirimycin accumulate in the endoplasmic reticulum. The Journal of Biological Chemistry. August 1984, 259 (16): 10129–35. PMID 6236213. doi:10.1016/S0021-9258(18)90939-7.
Dreyer RN, Bausch KM, Fracasso P, Hammond LJ, Wunderlich D, Wirak DO, Davis G, Brini CM, Buckholz TM, König G. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. European Journal of Biochemistry. September 1994, 224 (2): 265–71. PMID 7523115. doi:10.1111/j.1432-1033.1994.00265.x.
Atkins KB, Troen BR. Regulation of cathepsin D gene expression in HL-60 cells by retinoic acid and calcitriol. Cell Growth & Differentiation. July 1995, 6 (7): 871–7. PMID 7547509.